LXU LSB INDUSTRIES, INC.
Industrial Inorganic Chemicals · NYSE · SEC CIK 60714 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY13.0%
TTM net income YoY6,982.5%
TTM EPS YoY6,400.0%
Revenue 3-yr CAGR-1.6%
Net income 3-yr CAGR-22.6%
Margins
Gross margin19.9%
Operating margin11.2%
Net margin7.0%
FCF margin9.7%
EBITDA margin24.3%
Returns
ROE8.7%
ROA3.9%
ROIC (approx.)6.9%
Asset turnover0.56x
Leverage & solvency
Liabilities / assets54.4%
Debt / equity0.79x
Current ratio3.01x
Interest coverage2.61x
Cash quality & payout
Operating cash flow / net income3.25x
Accruals ratio-8.7%
Payout ratio—
Capex / revenue12.9%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $615.21M | $522.40M | $593.71M | $901.71M | $556.24M |
| Cost of revenue | $510.91M | $474.60M | $507.45M | $553.34M | $417.26M |
| Gross profit | $104.30M | $47.80M | $86.26M | $348.37M | $138.98M |
| SG&A expense | $41.51M | $41.77M | $36.58M | $39.43M | $38.03M |
| Operating income | $57.27M | -$5.50M | $51.78M | $308.38M | $101.05M |
| Interest expense | $30.66M | $34.45M | $41.14M | $46.83M | $49.38M |
| Pretax income | $32.55M | -$26.04M | $33.90M | $269.52M | $38.99M |
| Income tax | $7.94M | -$6.68M | $5.97M | $39.17M | -$4.56M |
| Net income | $24.61M | -$19.35M | $27.92M | $230.35M | $43.55M |
| EBITDA | $139.20M | $68.97M | $120.70M | $375.31M | $169.74M |
| EPS (basic) | 0.34 | -0.27 | 0.37 | 2.72 | -4.40 |
| EPS (diluted) | 0.34 | -0.27 | 0.37 | 2.68 | -4.40 |
| Weighted avg. shares (diluted) | 72.36M | 71.97M | 75.10M | 86.03M | 49.96M |
| Balance sheet | |||||
| Cash & equivalents | $19.51M | $20.23M | $98.50M | $63.77M | $82.14M |
| Short-term investments | $128.96M | $163.97M | $207.43M | $330.55M | — |
| Receivables | $57.21M | $38.76M | $40.38M | $74.80M | $86.43M |
| Inventory | $18.31M | $24.90M | $28.13M | $30.88M | $16.58M |
| Current assets | $293.29M | $309.71M | $436.74M | $566.60M | $243.14M |
| PP&E, net | $833.52M | $847.57M | $835.30M | $848.66M | $858.48M |
| Total assets | $1.17B | $1.19B | $1.30B | $1.44B | $1.13B |
| Current liabilities | $105.51M | $135.63M | $118.53M | $142.31M | $104.93M |
| Short-term debt | $760,000 | $9.12M | $5.85M | $9.52M | $9.45M |
| Long-term debt | $440.30M | $476.16M | $575.87M | $702.73M | $518.19M |
| Total debt | $441.06M | $485.28M | $581.72M | $712.25M | $527.64M |
| Total liabilities | $653.57M | $695.55M | $779.85M | $923.95M | $672.35M |
| Shareholders' equity | $519.97M | $491.64M | $518.33M | $515.87M | $460.49M |
| Net debt | $421.54M | $465.05M | $483.22M | $648.49M | $445.50M |
| Shares outstanding | — | — | — | — | 54.40M |
| Cash flow statement | |||||
| Operating cash flow | $95.52M | $86.58M | $137.52M | $345.65M | $87.63M |
| Capital expenditure | $77.46M | $92.29M | $67.60M | $45.83M | $35.13M |
| Free cash flow | $18.06M | -$5.72M | $69.92M | $299.82M | $52.50M |
| Investing cash flow | -$42.36M | -$53.08M | $57.40M | -$369.74M | -$34.69M |
| Financing cash flow | -$53.88M | -$114.30M | -$157.66M | $5.71M | $12.95M |
| Depreciation & amortization | $81.93M | $74.48M | $68.92M | $66.94M | $68.69M |
| Stock-based compensation | $7.37M | $6.61M | $5.35M | $4.03M | $5.52M |
Free plan shows the latest 5 periods; Pro shows all 17 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.